WeVote
Log In

Bill

Bill

S 1794

SNAP Next Step Act of 2025

119th Congress Introduced by Kirsten Gillibrand and 1 co-sponsor

Bill S 1794 ensures federally qualified and rural health centers can sustainably provide ovulation-enhancing drugs, improving access for patients seeking fertility treatments.

Introduced in Senate
0
WeVote Research Nonpartisan
Bill Summary · S 1794

Summary of Bill S 1794

Bill Information

  • Bill Number: S 1794
  • Title: Requires DOH to develop a payment methodology for federally qualified health centers and rural health centers that dispense ovulation enhancing drugs
  • Status: Referred to Health
  • Introduced: January 13, 2025
  • Classification: Bill

Purpose and Intent

Bill S 1794 aims to establish a structured payment methodology for federally qualified health centers (FQHCs) and rural health centers (RHCs) that provide ovulation-enhancing drugs. The intent of this legislation is to ensure that these healthcare facilities can sustainably offer these essential medications, which may be critical for individuals seeking fertility treatments.

Key Provisions

  • Development of Payment Methodology: The bill mandates the Department of Health (DOH) to create a payment system specifically for FQHCs and RHCs that dispense ovulation-enhancing drugs. This methodology will likely address reimbursement rates and ensure that these centers can adequately cover the costs associated with providing these medications.
  • Focus on Accessibility: By establishing a payment framework, the bill seeks to improve access to ovulation-enhancing drugs for patients who rely on these healthcare centers, particularly in underserved areas.

Who Would Be Affected

  • Federally Qualified Health Centers (FQHCs): These centers provide comprehensive healthcare services to underserved populations and would benefit from a clear payment structure for dispensing ovulation-enhancing drugs.
  • Rural Health Centers (RHCs): Similar to FQHCs, RHCs serve rural communities and would also be impacted positively by the proposed payment methodology.
  • Patients Seeking Fertility Treatments: Individuals seeking ovulation-enhancing medications would benefit from improved access and potentially lower costs associated with these drugs.

Procedural Aspects

  • Current Status: As of January 13, 2025, the bill has been referred to the Health Committee for further consideration.
  • Related Legislation:
    • A 2397: This is a companion bill that may address similar issues or provisions.
    • S 9159: A prior-session bill that may provide context or background relevant to the current legislation.

Conclusion

Bill S 1794 represents an important step towards enhancing the availability of ovulation-enhancing drugs through federally qualified and rural health centers. By developing a clear payment methodology, the bill aims to support healthcare providers in delivering essential fertility treatments to those in need, particularly in underserved areas. The ongoing legislative process will determine the final structure and implications of this bill.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.